| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225715 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Bortezomib in combination with radiation therapy and cisplatin chemotherapy is safe in the treatment of HNC with a bortezomib maximum tolerated dose of 1.0 mg/m2 in patients previously treated for HNC and 1.3 mg/m2 in radiation-naive patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Gregory J. M.D., Rita S. M.D., Mitchell M.D., Peter H. M.D., Pramila R. M.D., Shannon M.D., David M.D., Thomas J. M.D., Walter J. M.D., Adam P. M.D., Ph.D.,